These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 24121928)

  • 1. High-throughput identification of antigen-specific TCRs by TCR gene capture.
    Linnemann C; Heemskerk B; Kvistborg P; Kluin RJ; Bolotin DA; Chen X; Bresser K; Nieuwland M; Schotte R; Michels S; Gomez-Eerland R; Jahn L; Hombrink P; Legrand N; Shu CJ; Mamedov IZ; Velds A; Blank CU; Haanen JB; Turchaninova MA; Kerkhoven RM; Spits H; Hadrup SR; Heemskerk MH; Blankenstein T; Chudakov DM; Bendle GM; Schumacher TN
    Nat Med; 2013 Nov; 19(11):1534-41. PubMed ID: 24121928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.
    Kobayashi E; Mizukoshi E; Kishi H; Ozawa T; Hamana H; Nagai T; Nakagawa H; Jin A; Kaneko S; Muraguchi A
    Nat Med; 2013 Nov; 19(11):1542-6. PubMed ID: 24121927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.
    Chen L; Dong L; Ma Y; Wang J; Qiao D; Tian G; Wang M
    BMC Immunol; 2021 Sep; 22(1):65. PubMed ID: 34583647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput discovery of cancer-targeting TCRs.
    Bunse L; Green EW; Platten M
    Methods Enzymol; 2019; 629():401-417. PubMed ID: 31727251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
    Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
    Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.
    Lu YC; Zheng Z; Robbins PF; Tran E; Prickett TD; Gartner JJ; Li YF; Ray S; Franco Z; Bliskovsky V; Fitzgerald PC; Rosenberg SA
    Mol Ther; 2018 Feb; 26(2):379-389. PubMed ID: 29174843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
    Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR validation toward gene therapy for cancer.
    Green EW; Bunse L; Bozza M; Sanghvi K; Platten M
    Methods Enzymol; 2019; 629():419-441. PubMed ID: 31727252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
    Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
    J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
    Bendle GM; Linnemann C; Hooijkaas AI; Bies L; de Witte MA; Jorritsma A; Kaiser AD; Pouw N; Debets R; Kieback E; Uckert W; Song JY; Haanen JB; Schumacher TN
    Nat Med; 2010 May; 16(5):565-70, 1p following 570. PubMed ID: 20400962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function.
    Thomas S; Mohammed F; Reijmers RM; Woolston A; Stauss T; Kennedy A; Stirling D; Holler A; Green L; Jones D; Matthews KK; Price DA; Chain BM; Heemskerk MHM; Morris EC; Willcox BE; Stauss HJ
    Nat Commun; 2019 Oct; 10(1):4451. PubMed ID: 31575864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.
    Simon P; Omokoko TA; Breitkreuz A; Hebich L; Kreiter S; Attig S; Konur A; Britten CM; Paret C; Dhaene K; Türeci Ö; Sahin U
    Cancer Immunol Res; 2014 Dec; 2(12):1230-44. PubMed ID: 25245536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needle in a Haystack: The Naïve Repertoire as a Source of T Cell Receptors for Adoptive Therapy with Engineered T Cells.
    D'Ippolito E; Wagner KI; Busch DH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Framework for Annotation of Antigen Specificities in High-Throughput T-Cell Repertoire Sequencing Studies.
    Pogorelyy MV; Shugay M
    Front Immunol; 2019; 10():2159. PubMed ID: 31616409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral precision T cell receptor replacement for personalized cell therapy.
    Foy SP; Jacoby K; Bota DA; Hunter T; Pan Z; Stawiski E; Ma Y; Lu W; Peng S; Wang CL; Yuen B; Dalmas O; Heeringa K; Sennino B; Conroy A; Bethune MT; Mende I; White W; Kukreja M; Gunturu S; Humphrey E; Hussaini A; An D; Litterman AJ; Quach BB; Ng AHC; Lu Y; Smith C; Campbell KM; Anaya D; Skrdlant L; Huang EY; Mendoza V; Mathur J; Dengler L; Purandare B; Moot R; Yi MC; Funke R; Sibley A; Stallings-Schmitt T; Oh DY; Chmielowski B; Abedi M; Yuan Y; Sosman JA; Lee SM; Schoenfeld AJ; Baltimore D; Heath JR; Franzusoff A; Ribas A; Rao AV; Mandl SJ
    Nature; 2023 Mar; 615(7953):687-696. PubMed ID: 36356599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.
    Li Z; Ma L; Gao Z; Wang X; Che X; Zhang P; Li Y; Zhang Q; Liu T; Sun Y; Bai Y; Deng H
    Cancer Immunol Immunother; 2024 Jul; 73(9):164. PubMed ID: 38954022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response.
    He J; Xiong X; Yang H; Li D; Liu X; Li S; Liao S; Chen S; Wen X; Yu K; Fu L; Dong X; Zhu K; Xia X; Kang T; Bian C; Li X; Liu H; Ding P; Zhang X; Liu Z; Li W; Zuo Z; Zhou P
    Cell Res; 2022 Jun; 32(6):530-542. PubMed ID: 35165422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.